# Fedex Corp: overview

FDX · NYSE · CIK 1048911 · [Industrials](/sectors/industrials.md) · fiscal year ends May 31

Pages: [Overview](/companies/fdx.md) · [Financials](/companies/fdx/financials.md) · [Filings](/companies/fdx/filings.md) · [Insiders](/companies/fdx/insiders.md)

Latest reported revenue: [$25.01bn](/filings/0001048911-26-000105.md) for Q4 FY2026, three months to 2026-05-31, from the 10-K filed Jul 20, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001048911-26-000105).

## Last eight quarters

| Line item | Unit | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [21.6](/filings/0001048911-25-000044.md) | [22.0](/filings/0001048911-25-000078.md) | [22.2](/filings/0001048911-26-000011.md) | [22.2 d](/filings/0001048911-26-000105.md) | [22.2](/filings/0001048911-25-000044.md) | [23.5](/filings/0001048911-25-000078.md) | [24.0](/filings/0001048911-26-000011.md) | [25.0 d](/filings/0001048911-26-000105.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [5.0%](/filings/0001048911-25-000044.md) | [4.8%](/filings/0001048911-25-000078.md) | [5.8%](/filings/0001048911-26-000011.md) | [8.1% d](/filings/0001048911-26-000105.md) | [5.3%](/filings/0001048911-25-000044.md) | [5.9%](/filings/0001048911-25-000078.md) | [5.6%](/filings/0001048911-26-000011.md) | [6.2% d](/filings/0001048911-26-000105.md) |
| Net margin | % | [3.7%](/filings/0001048911-25-000044.md) | [3.4%](/filings/0001048911-25-000078.md) | [4.1%](/filings/0001048911-26-000011.md) | [7.4% d](/filings/0001048911-26-000105.md) | [3.7%](/filings/0001048911-25-000044.md) | [4.1%](/filings/0001048911-25-000078.md) | [4.4%](/filings/0001048911-26-000011.md) | [6.4% d](/filings/0001048911-26-000105.md) |
| Diluted EPS | $ per share | [3.21](/filings/0001048911-25-000044.md) | [3.03](/filings/0001048911-25-000078.md) | [3.76](/filings/0001048911-26-000011.md) | not reported | [3.46](/filings/0001048911-25-000044.md) | [4.04](/filings/0001048911-25-000078.md) | [4.41](/filings/0001048911-26-000011.md) | not reported |
| Free cash flow | $bn | [0.4](/filings/0001048911-25-000044.md) | [0.5 d](/filings/0001048911-25-000078.md) | [1.0 d](/filings/0001048911-26-000011.md) | [1.0 d](/filings/0001048911-26-000105.md) | [1.1](/filings/0001048911-25-000044.md) | [1.2 d](/filings/0001048911-25-000078.md) | [1.0 d](/filings/0001048911-26-000011.md) | [1.8 d](/filings/0001048911-26-000105.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-05-31) | FY2023 (2023-05-31) | FY2024 (2024-05-31) | FY2025 (2025-05-31) | FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [93.5](/filings/0000950170-24-083577.md) | [90.2](/filings/0001048911-25-000011.md) | [87.7](/filings/0001048911-26-000105.md) | [87.9](/filings/0001048911-26-000105.md) | [94.7](/filings/0001048911-26-000105.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [6.7%](/filings/0000950170-24-083577.md) | [5.4%](/filings/0001048911-25-000011.md) | [6.3%](/filings/0001048911-26-000105.md) | [5.9%](/filings/0001048911-26-000105.md) | [5.8%](/filings/0001048911-26-000105.md) |
| Net margin | % | [4.1%](/filings/0000950170-24-083577.md) | [4.4%](/filings/0001048911-25-000011.md) | [4.9%](/filings/0001048911-26-000105.md) | [4.7%](/filings/0001048911-26-000105.md) | [4.7%](/filings/0001048911-26-000105.md) |
| Diluted EPS | $ per share | [14.33](/filings/0000950170-24-083577.md) | [15.48](/filings/0001048911-25-000011.md) | [17.21](/filings/0001048911-26-000105.md) | [16.81](/filings/0001048911-26-000105.md) | [18.55](/filings/0001048911-26-000105.md) |
| Free cash flow | $bn | [3.1](/filings/0000950170-24-083577.md) | [2.7](/filings/0001048911-25-000011.md) | [3.1](/filings/0001048911-26-000105.md) | [3.0](/filings/0001048911-26-000105.md) | [5.1](/filings/0001048911-26-000105.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fdx/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $6.51bn | 20,784,028 |  | Added +1,980,339 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $4.44bn | 14,181,180 |  | Added +280,190 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $3.16bn | 10,053,615 |  | Added +311,740 |
| [PRIMECAP MANAGEMENT CO/CA/](/funds/763212.md) | 2026-06-30 | $2.55bn | 8,156,799 |  | Reduced −146,211 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $2.30bn | 7,347,236 |  | Added +197,795 |
| [Dodge & Cox](/funds/200217.md) | 2026-06-30 | $2.26bn | 7,233,269 |  | Reduced −2,750,180 |
| [FRANKLIN RESOURCES INC](/funds/38777.md) | 2026-06-30 | $1.68bn | 5,364,782 |  | Reduced −530,452 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.62bn | 5,194,414 |  | Added +47,104 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $1.58bn | 5,040,208 |  | Reduced −1,234,728 |
| [NORGES BANK](/funds/1374170.md) | 2026-06-30 | $1.16bn | 3,716,680 |  | New +3,716,680 |

## Recent filings

[All 1,542 filings](/companies/fdx/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 16:26 ET | [10-Q](/filings/0001048911-26-000131.md) | Quarterly report, period 2026-09-30 | 0001048911-26-000131 |
| 2026-10-28 | 16:12 ET | [8-K](/filings/0001048911-26-000128.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048911-26-000128 |
| 2026-10-28 | 16:05 ET | [8-K](/filings/0001048911-26-000126.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048911-26-000126 |
| 2026-10-26 | 07:15 ET | [8-K](/filings/0001104659-26-118604.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-118604 |
| 2026-09-29 | 17:06 ET | [8-K](/filings/0001104659-26-111970.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-111970 |
| 2026-09-14 | 16:28 ET | [8-K](/filings/0001104659-26-107511.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-107511 |
| 2026-08-17 | 16:04 ET | [DEF 14A](/filings/0001104659-26-097836.md) | Proxy statement, period 2026-09-28 | 0001104659-26-097836 |
| 2026-07-24 | 16:05 ET | [8-K](/filings/0001104659-26-086643.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-086643 |
| 2026-07-21 | 16:09 ET | [8-K](/filings/0001048911-26-000108.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048911-26-000108 |
| 2026-07-20 | 16:14 ET | [10-K](/filings/0001048911-26-000105.md) | Annual report, period 2026-05-31 | 0001048911-26-000105 |

## Latest annual report

[Form 10-K for the fiscal year ended May 31, 2026](/filings/0001048911-26-000105.md), filed Jul 20, 2026.

## Forecast league

Q1 FY2027, the quarter ended 2026-08-31, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/659d58b7-0817-4b47-8fdf-e0a4511790df)

## About the filer

- CIK: 1048911
- Tickers: FDX
- Exchange: NYSE
- SIC code: 4513 Air Courier Services
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:55 ET. No prices; not investment advice.